Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 13032.16 | 2635 / 2642 | 100% | 80.22 | 704 / 705 |
breast | 99% | 2475.19 | 456 / 459 | 99% | 32.68 | 1111 / 1118 |
lung | 100% | 3979.16 | 577 / 578 | 98% | 29.67 | 1137 / 1155 |
thymus | 99% | 2303.98 | 645 / 653 | 99% | 28.03 | 598 / 605 |
uterus | 99% | 3085.40 | 169 / 170 | 96% | 24.92 | 441 / 459 |
kidney | 99% | 2494.53 | 88 / 89 | 96% | 31.13 | 866 / 901 |
intestine | 99% | 2814.11 | 956 / 966 | 94% | 18.13 | 494 / 527 |
esophagus | 94% | 2427.85 | 1352 / 1445 | 98% | 18.43 | 179 / 183 |
adrenal gland | 97% | 2329.88 | 250 / 258 | 93% | 18.53 | 213 / 230 |
bladder | 100% | 3526.81 | 21 / 21 | 89% | 18.80 | 449 / 504 |
skin | 88% | 1852.25 | 1585 / 1809 | 100% | 75.55 | 472 / 472 |
prostate | 93% | 1898.84 | 228 / 245 | 94% | 15.79 | 470 / 502 |
stomach | 86% | 1832.69 | 308 / 359 | 97% | 21.28 | 276 / 286 |
ovary | 72% | 1214.51 | 129 / 180 | 91% | 16.58 | 393 / 430 |
liver | 57% | 797.63 | 129 / 226 | 71% | 11.43 | 287 / 406 |
pancreas | 20% | 253.25 | 66 / 328 | 96% | 28.66 | 171 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 225.69 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.21 | 29 / 29 |
peripheral blood | 100% | 8702.79 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 7940.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.15 | 45 / 45 |
blood vessel | 100% | 5093.76 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3248.05 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 68% | 1221.18 | 585 / 861 | 0% | 0 | 0 / 0 |
muscle | 8% | 98.57 | 65 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000786 | Biological process | positive regulation of autophagosome assembly |
GO_0061909 | Biological process | autophagosome-lysosome fusion |
GO_1902635 | Biological process | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0035855 | Biological process | megakaryocyte development |
GO_0010506 | Biological process | regulation of autophagy |
GO_0090119 | Biological process | vesicle-mediated cholesterol transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0001750 | Cellular component | photoreceptor outer segment |
GO_0005764 | Cellular component | lysosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001917 | Cellular component | photoreceptor inner segment |
GO_0005829 | Cellular component | cytosol |
GO_0005776 | Cellular component | autophagosome |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0016308 | Molecular function | 1-phosphatidylinositol-4-phosphate 5-kinase activity |
GO_0016309 | Molecular function | 1-phosphatidylinositol-5-phosphate 4-kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PIP4K2A |
Protein name | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-Phosphate 4-Kinase) (PI5P4Kalpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha) Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PtdIns(5)P-4-kinase isoform 2-alpha) Alternative protein PIP4K2A |
Synonyms | PI5P4KA PIP5K2 PIP5K2A |
Description | FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol 5-phosphate (PtdIns5P) on the fourth hydroxyl of the myo-inositol ring, to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) . Has both ATP- and GTP-dependent kinase activities . May exert its function by regulating the levels of PtdIns5P, which functions in the cytosol by increasing AKT activity and in the nucleus signals through ING2 . May regulate the pool of cytosolic PtdIns5P in response to the activation of tyrosine phosphorylation (By similarity). Required for lysosome-peroxisome membrane contacts and intracellular cholesterol transport through modulating peroxisomal PtdIns(4,5)P2 level . In collaboration with PIP4K2B, has a role in mediating autophagy in times of nutrient stress (By similarity). Required for autophagosome-lysosome fusion and the regulation of cellular lipid metabolism . May be involved in thrombopoiesis, and the terminal maturation of megakaryocytes and regulation of their size (By similarity). Negatively regulates insulin signaling through a catalytic-independent mechanism . PIP4Ks interact with PIP5Ks and suppress PIP5K-mediated PtdIns(4,5)P2 synthesis and insulin-dependent conversion to PtdIns(3,4,5)P3 . . |
Accessions | ENST00000604912.1 ENST00000545335.5 [P48426-2] S4R320 ENST00000376573.9 [P48426-1] L8EAD2 H7BXS3 P48426 ENST00000323883.11 |